184 related articles for article (PubMed ID: 26162864)
1. AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.
Tuan EW; Horti AG; Olson TT; Gao Y; Stockmeier CA; Al-Muhtasib N; Bowman Dalley C; Lewin AE; Wolfe BB; Sahibzada N; Xiao Y; Kellar KJ
Mol Pharmacol; 2015 Oct; 88(4):640-9. PubMed ID: 26162864
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR.
Zaveri NT; Bertrand S; Yasuda D; Bertrand D
Nicotine Tob Res; 2015 Mar; 17(3):361-7. PubMed ID: 25180076
[TBL] [Abstract][Full Text] [Related]
3. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
4. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
6. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.
Chatterjee S; Steensland P; Simms JA; Holgate J; Coe JW; Hurst RS; Shaffer CL; Lowe J; Rollema H; Bartlett SE
Neuropsychopharmacology; 2011 Feb; 36(3):603-15. PubMed ID: 21048701
[TBL] [Abstract][Full Text] [Related]
7. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
[TBL] [Abstract][Full Text] [Related]
8. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
[TBL] [Abstract][Full Text] [Related]
9. [¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.
Wu J; Perry DC; Bupp JE; Jiang F; Polgar WE; Toll L; Zaveri NT
Neuropharmacology; 2014 Feb; 77():193-9. PubMed ID: 24095990
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.
Wageman CR; Marks MJ; Grady SR
Nicotine Tob Res; 2014 Mar; 16(3):297-305. PubMed ID: 24052501
[TBL] [Abstract][Full Text] [Related]
11. Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine.
Hauser TA; Hepler CD; Kombo DC; Grinevich VP; Kiser MN; Hooker DN; Zhang J; Mountfort D; Selwood A; Akireddy SR; Letchworth SR; Yohannes D
Neuropharmacology; 2012 Jun; 62(7):2239-50. PubMed ID: 22306792
[TBL] [Abstract][Full Text] [Related]
12. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Boess FG; de Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; König G
Psychopharmacology (Berl); 2013 May; 227(1):1-17. PubMed ID: 23241647
[TBL] [Abstract][Full Text] [Related]
14. High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.
Khroyan TV; Yasuda D; Toll L; Polgar WE; Zaveri NT
Biochem Pharmacol; 2015 Oct; 97(4):531-541. PubMed ID: 26256075
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
[TBL] [Abstract][Full Text] [Related]
16. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
[TBL] [Abstract][Full Text] [Related]
17. Determinants for α4β2 vs. α3β4 Subtype Selectivity of Pyrrolidine-Based nAChRs Ligands: A Computational Perspective with Focus on Recent cryo-EM Receptor Structures.
Bavo F; Pallavicini M; Appiani R; Bolchi C
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204637
[TBL] [Abstract][Full Text] [Related]
18. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
19. The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4).
Pym LJ; Buckingham SD; Tsetlin V; Boyd CA; Sattelle DB
Neurosci Lett; 2007 Oct; 427(1):28-33. PubMed ID: 17945421
[TBL] [Abstract][Full Text] [Related]
20. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
Cohen C; Bergis OE; Galli F; Lochead AW; Jegham S; Biton B; Leonardon J; Avenet P; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Voltz C; Gardes A; Caille D; Perrault G; George P; Soubrie P; Scatton B
J Pharmacol Exp Ther; 2003 Jul; 306(1):407-20. PubMed ID: 12682217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
